Starting in 2026, Californians will be able to buy prescription insulin pens for $11. Through CalRx and a partnership with manufacturers, Californians will be able to buy discounted insulin from the ...

The state accuses the pharmaceutical giant of colluding with other insulin makers to hike the price by more than 1,000% over ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Attorney General Todd Rokita filed a lawsuit against Eli Lilly and Company, claiming the drugmaker has conspired to raise ...

Indiana Attorney General Todd Rokita has filed a lawsuit against Eli Lilly and Company, alleging that the drugmaker has ...

California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

Forbes contributors publish independent expert analyses and insights. Errol Schweizer has the essential take on the grocery industry. According to Stacy Mitchell of the Institute for Local Reliance ...

Case follows FTC’s decision to drop a Robinson-Patman Act lawsuit against Pepsi PepsiCo and Walmart have been accused in a new consumer class action lawsuit of orchestrating a decade-long price-fixing ...

Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years. Kleck, 32, of Santa Cruz, was diagnosed with the rarer Type 1 diabetes at age ...

California’s new CalRx program will offer state-made, low-cost insulin, giving Kern County residents easier access to an ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...